News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Mohamed Abdelaziz: Atezolizumab and Bevacizumab versus Sorafenib in Egyptian HCC patients
Abdallah Khalil, Mohamed Abdelaziz and Tamer El Nahas
Dec 20, 2024, 09:06

Mohamed Abdelaziz: Atezolizumab and Bevacizumab versus Sorafenib in Egyptian HCC patients

Mohamed Abdelaziz, National Oncology Committee member at Ministry of Health and Population in Egypt and Intern Fellow at Gustave Roussy, shared on LinkedIn:

“Thrilled to share the publication of our recent poster presented in ESMO ASIA.

Tackling the benefit of atezo/beva vs sorafenib in Egyptian HCC patients.”

235P Combined atezolizumab and bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma: A single center experience

Authors: A.A. Khalil, M.A. Abdelaziz, T.I. El Nahas

Mohamed abdelaziz
Further Reading:

Highlights from Day 1 of ESMO Asia 2024

Highlights from Day 2 of ESMO Asia 2024

Highlights from Day 3 of ESMO Asia 2024

Best of ESMO Asia 2024

Abdallah Khalil Atezolizuma Bevacizumab cancer ESMO Asia 2024 Hepatocellular carcinoma (HCC) Mohamed Abdelaziz OncoDaily Oncology sorafenib Tamer El Nahas
Special Coverage
Blog
Feb 1, 2025, 09:39
Stephen V Liu: Connecting with friends from the lung cancer community at ITCD2025
Blog
Feb 1, 2025, 09:27
Giselle Sholler: Thrilled to collaborate with Nature’s Toolbox to pioneer personalized RNA vaccines
Blog
Feb 1, 2025, 09:13
9th Annual Conference of ELLOK - "Person Centered Care: From Planning to Implementation"
Insight
Feb 1, 2025, 09:08
Why is Survivorship Passport essential? - PanCare
Blog
Feb 1, 2025, 09:05
Justin Stebbing: Air pollution may protect against skin cancer, but the health risks are far more serious
Blog
Feb 1, 2025, 09:02
Implementing Palliative Care in Karongi District - ACREOL Global
Insight
Feb 1, 2025, 08:57
Mohamed Emam Sobeih: Honored to have my abstract presented in the upcoming ELLC 2025 In Paris
Opinion
Feb 1, 2025, 08:53
Liang Cheng: Is Axillary Lymph Node Dissection Needed?
Opinion
Feb 1, 2025, 08:50
Sharlene Gill: Great summary of best practices to increase wellness and decrease burnout in oncology
Blog
Feb 1, 2025, 08:47
Lavondia Alexander: Grateful to serve as board co-chair of the Atrium Health Cancer Center Community Advisory Board
Blog
Feb 1, 2025, 08:47
Sewanti Limaye: New horizons in oncology at Illuminate - Oncology Townhall 2.0 together
Blog
Feb 1, 2025, 08:46
Adamu Alhassan Umar: Prevention is better, safer and cheaper than cure